siRNA therapy reduces triglycerides in clients with rare health condition
.RESEARCH STUDY FEATURE.19 September 2024.
Plozasiran lessened triglyceride amounts by 80% as well as lowered the danger of pancreatitis in patients along with persistent chylomicronemia, along with or even without a genetic diagnosis.